HealthcareServices

Cancer Tumor Profiling Market Forecast 2026: Where the Industry Is Headed

February 20, 2026February 23, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the cancer tumor profiling market from 2026–2035 with trusted insights from The Business Research Company

What are the forecasted starting (2026) and ending (2030) market sizes for the Cancer Tumor Profiling Market?

The cancer tumor profiling market size has experienced rapid expansion in recent years. Projections indicate it will expand from $14.97 billion in 2025 to $17.1 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 14.3%. Historically, this market’s expansion was driven by several factors, including the increased adoption of tumor biopsy testing, the broadening of oncology research initiatives, the early integration of molecular stratification in clinical settings, the rise of hospital-based profiling offerings, and the enhanced availability of sophisticated laboratory infrastructure.

The cancer tumor profiling market size is anticipated to experience substantial growth in the coming years. It is projected to expand to $28.27 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 13.4%. This growth during the forecast period can be attributed to several factors, including the increasing demand for precision oncology decision-making, the expansion of personalized cancer therapies, growing investments in translational research, the rising adoption of advanced sequencing technologies, and an increasing focus on predictive oncology diagnostics. Major trends identified for the forecast period encompass the increasing use of multi-omics tumor profiling, the rising adoption of targeted sequencing panels, the growing integration of AI-driven biomarker analysis, the expansion of personalized treatment planning, and an enhanced focus on prognostic profiling.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=6053&type=smp

What Drivers Are Supporting Technological Adoption In The Cancer Tumor Profiling Market?

A rising global occurrence of cancer is projected to fuel the expansion of the cancer and tumor profiling market. This condition involves the unchecked proliferation of specific body cells that subsequently disseminate to other regions. The growing count of cancer diagnoses correlates with an increased need for cancer tumor profiling, a tool that assists medical professionals in assessing disease severity. For example, in 2024, the American Cancer Society, a US-based professional organization, documented 2 million new cancer cases in the country, an increase from 1.9 million new cases in 2023. Consequently, the growing global incidence of cancer is a primary catalyst for the development of the cancer and tumor profiling market.

What Segment Types Are Examined In The Cancer Tumor Profiling Market?

The cancer tumor profiling market covered in this report is segmented –

1) By Cancer Type: Lung Cancer, Breast Cancer, Colorectal Cancer, Prostate Cancer, Melanoma, Ovarian Cancer, Stomach Cancer, Pancreatic Cancer, Thyroid Cancer, Other Cancer Types

2) By Technology: Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Immunohistochemistry (IHC), In Situ Hybridization (ISH), Microarray, Other Technologies

3) By Process Type: Genomics, Proteomics, Epigenetics, Other Types

4) By Application: Personalized Medicine, Diagnostics, Biomarker Discovery, Prognostics, Research Applications

Subsegments:

1) By Lung Cancer: Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC)

2) By Breast Cancer: Hormone Receptor-Positive, Triple-Negative Breast Cancer, HER2-Positive Breast Cancer

3) By Colorectal Cancer: Colon Cancer, Rectal Cancer

4) By Prostate Cancer: Localized Prostate Cancer, Advanced Prostate Cancer

5) By Melanoma: Cutaneous Melanoma, Non-Cutaneous Melanoma

6) By Ovarian Cancer: Epithelial Ovarian Cancer, Non-Epithelial Ovarian Cancer

7) By Stomach Cancer: Gastric Adenocarcinoma, Gastrointestinal Stromal Tumors (GISTs)

8) By Pancreatic Cancer: Exocrine Pancreatic Cancer, Neuroendocrine Tumors

9) By Thyroid Cancer: Papillary Thyroid Cancer, Follicular Thyroid Cancer, Medullary Thyroid Cancer

10) By Other Cancer Types: Kidney Cancer, Bladder Cancer, Liver Cancer, Esophageal Cancer

Who Are The Primary Competitors In The Global Cancer Tumor Profiling Market?

Major companies operating in the cancer tumor profiling market are F. Hoffmann-La Roche Ltd., Caris Life Sciences, Thermo Fisher Scientific Inc., Illumina Inc., Qiagen, HTG Molecular Diagnostics Inc., NanoString Technologies Inc., NeoGenomics Laboratories Inc., Lucence Health Inc., ACT Genomics Co. LTD, Strand Life Sciences, Exact Sciences Corporation, Guardant Health, Foundation Medicine Inc., Agilent Technologies Inc., Myriad Genetics Inc., Personal Genome Diagnostics Inc., Tempus Labs Inc., ArcherDX Inc., Natera Inc., Bio-Rad Laboratories Inc., Genetron Health, NantHealth Inc., Resolution Bioscience, OncoDNA, Strata Oncology Inc., RareCyte Inc., Inivata Limited, Cepheid

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/cancer-tumor-profiling-global-market-report

Which Global Regions Are Shaping The Competitive Landscape Of The Cancer Tumor Profiling Market?

North America was the largest region in cancer and tumor profiling market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cancer tumor profiling market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Cancer Tumor Profiling Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=6053&type=smp

Browse Through More Reports Similar to the Global Cancer Tumor Profiling Market 2026, By The Business Research Company

Cancer Diagnostics Market Report 2026

https://www.thebusinessresearchcompany.com/report/cancer-diagnostics-global-market-report

Cancer Profiling Market Report 2026

https://www.thebusinessresearchcompany.com/report/cancer-profiling-global-market-report

Cancer Biomarker Market Report 2026

https://www.thebusinessresearchcompany.com/report/cancer-biomarker-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795